M Ünal, I Yücel - British Medical Journal, 2008 - bjo.bmj.com Patients and methods: A total of 47 high-risk keratoplasties were randomly
divided into two groups based on the postoperative immunosuppression.
Twenty-five eyes (group 1) were treated with 0.05% ciclosporin and ... Cited by 1 - Related articles - All 3 versions
M Ünal, Ý Yücel - bjo.bmj.com Page 1. doi: 10.1136/bjo.2008.143024 published online July 28, 2008 Br
J Ophthalmol Mustafa Ünal and Ýclal Yücel prevention of ... Related articles - All 2 versions
F Birnbaum, A Reis, T Reinhard - Der Ophthalmologe: Zeitschrift der Deutschen …, 2007 - ncbi.nlm.nih.gov Topical steroids are routinely used in the postoperative treatment following
penetrating keratoplasty. Due to the known side effects such as steroid-response
glaucoma, cataract, and surface disorders, a broader armamentarium of ... Cited by 4 - Related articles
JL Bourges, F Lallemand, E Agla, K … - Mol Vis, 2006 - molvis.org Methods: Corneas of Brown-Norway rats (donors) were transplanted to Lewis rats
(recipients). Transplanted rats were divided in three treatment groups: group I
(PBS) and group II (0.26% Debio088) received drops five times per day. ... Cited by 6 - Related articles - Cached - All 3 versions
KF Tabbara - International ophthalmology, 2008 - Springer Abstract Corneal transplantation remains one of the most successful organ
transplantation procedures in humans. The unique structure of the cornea, with
its absence of blood vessels and corneal lymphatic, allows the survival of ... Cited by 4 - Related articles - BL Direct - All 3 versions
KC Yoon, H Heo, IS Kang, MC Lee, KK Kim, … - Cornea, 2008 - journals.lww.com From the *Department of Ophthalmology, †Department of Pathology, and
‡Department of Pharmacology, Chonnam National University Medical School,
Gwangju, Korea; and the §Bio-therapy Human Resources Center, College of ... Cited by 3 - Related articles - BL Direct - All 3 versions
K Inoue, S Amano, C Kimura, T Sato, N Fujita, … - Nippon Ganka Gakkai zasshi, 1999 - ncbi.nlm.nih.gov PURPOSE: To evaluate the long-term outcome of 2% topical cyclosporine A (CsA)
treatment as an adjunct to topical corticosteroid in 86 eyes after penetrating
keratoplasty (PK). MATERIAL AND METHODS: The subjects were 86 eyes of 83 ... Cited by 3 - Related articles - BL Direct - All 4 versions
